Mediastinoscopy. Its application in central versus peripheral thoracic lesions

Mediastinoscopy is a diagnostic tool used to assess mediastinal lymph nodes in thoracic conditions. Prior research has shown its effectiveness in central lung lesions and in cases with visible mediastinal nodes on imaging. However, the utility of this procedure in peripheral lung lesions remains unclear. No prior work had resolved whether mediastinoscopy is equally effective across lesion types. This gap motivated a closer examination of cervicomediastinal exploration (CME) outcomes. The procedure's role in peripheral lesions without mediastinal nodal involvement is uncertain. Existing evidence suggests high diagnostic yield in central lesions. But peripheral cases with and without nodal involvement show variable results. Understanding this distinction could refine diagnostic strategies in thoracic medicine.

This study aimed to evaluate the diagnostic accuracy of cervicomediastinal exploration (CME) for peripheral lung lesions. The researchers focused on comparing outcomes between central and peripheral lesions. They also examined the impact of mediastinal nodal involvement on diagnostic success. The goal was to determine when CME is most useful in thoracic diagnostics. By analyzing patient records, they sought to clarify the procedure's limitations and strengths. The study specifically addressed whether mediastinal nodal presence affects diagnostic yield. They wanted to distinguish between lesion types and their diagnostic implications. This information could guide clinical decisions on when to use CME effectively.

The study reviewed medical records of 157 patients who underwent cervicomediastinal exploration (CME) at Wilford Hall USAF Medical Center. Patient data were categorized by lesion type—central or peripheral—and by presence or absence of mediastinal nodes on roentgenogram. Diagnostic outcomes were analyzed separately for benign and malignant lesions. The researchers calculated diagnostic yield as positive results in each subgroup. They compared results across groups to assess CME's effectiveness. No additional diagnostic tools were used beyond CME and roentgenography. The analysis focused on whether nodal involvement influenced diagnostic success. The study design was retrospective and descriptive in nature.

CME was positive in 90.6% of benign central lesions and 58.3% of benign peripheral lesions. In benign cases with mediastinal nodes on roentgenogram, CME was 100% positive. In benign peripheral lesions without nodes, CME was 100% negative. For malignant central lesions, CME was positive in 72.9% of cases. Malignant peripheral lesions showed a 58.1% positive rate. Among peripheral malignant lesions with nodes, 24 of 27 cases were positive. In peripheral malignant lesions without nodes, 15 of 16 cases were negative. These results suggest diagnostic accuracy varies with lesion type and nodal involvement.

The authors propose that CME is valuable in central lesions and peripheral lesions with mediastinal nodal involvement. They suggest that CME is less useful in peripheral lesions without nodal involvement. The diagnostic yield in benign peripheral cases with nodes was 100%. In benign peripheral cases without nodes, CME was 100% negative. For malignant peripheral lesions with nodes, 24 of 27 cases were positive. For malignant peripheral lesions without nodes, 15 of 16 were negative. These findings align with the authors' claim that nodal presence is a key factor in diagnostic success. The study does not propose generalizations beyond the observed patterns.